Board of Directors

Chaim Indig, Chief Executive Officer and Board Member

Since co-founding Phreesia in 2005, Chaim Indig has helped revolutionize the patient intake experience. Under his leadership, Phreesia has established a broad national footprint, developed strategic partnerships with some of the world’s largest healthcare companies, and earned accolades for its role in making healthcare more efficient and patient-centered.

Prior to founding Phreesia, he held key roles at Spotfire and OLAP@Work. Chaim is also a recognized business leader, trusted industry expert and sought-after speaker. He was a finalist for Ernst & Young’s “Entrepreneur of the Year” Award and was featured in the Stanford Social Innovation Review as a healthcare innovator.

Edward L. Cahill, Board Member

Ed is a partner at HLM Venture Partners. Previously, he was a founding partner of Cahill, Warnock & Co. (now Camden Partners) and a managing director at Alex. Brown & Sons, where he headed the firm’s healthcare group. During his leadership at Alex. Brown & Sons, the firm underwrote public offerings or provided merger advisory services for over 200 healthcare companies and several leading biopharmaceutical companies. Ed is a director at Masimo Corp. and a trustee of Johns Hopkins Medicine, the Johns Hopkins Health System Corp. and Mercy Health Services.

Scott Perricelli, Board Member

With more than 15 years of private equity and investment banking experience, Scott leads LLR Partners’ investments in healthcare and education services. Prior to joining LLR, Scott was a principal at Draper Triangle Ventures, an investor in high-technology startup companies in Ohio and Pennsylvania. Earlier in his career, Scott served as an associate at Advanta Partners, and worked in investment banking at William Blair & Co. and JP Morgan and Co. Scott’s current investments include Phreesia, IOD Incorporated, Physicians Immediate Care, Regency Beauty Institute, Vector Learning and Vivere Health.

Michael Weintraub, Chairman

Michael was most recently Managing Partner of Optum Ventures, a leading health services company focused on digital health innovation. He also co-founded and served as CEO of Humedica, a pioneer and leader in the field of population health management and big data. In 2013, Humedica was acquired by UnitedHealth Group (UHG), and he broadened his role within the company to become President and CEO of Optum Analytics. Prior to launching Humedica, Michael served as Senior Managing Director at Leerink Partners, a leading healthcare investment bank. Michael was also President and CEO of PHARMetrics, a healthcare informatics company, which was successfully sold to IMS Health in 2005.

He serves as Founding Chairman of the Board of Phreesia, as well as Chairman of the Board of BroadReach, a global healthcare company headquartered in Cape Town, South Africa. He is an Entrepreneur in Residence at Harvard Business School, focused on healthcare innovation, and a mentor and speaker at the Harvard Innovation Lab (iLab), a unique collaboration and education space designed to foster entrepreneurship. Michael is an advisor at the GLG Institute, a community of senior executives exchanging leadership and operational experience. He is also an Advisory Board member of the Innovation and Digital Health Accelerator at Boston Children’s Hospital. Michael is a member of the Board of Directors of The College Diabetes Network (CDN), whose mission is to empower and improve the lives of students living with Type 1 diabetes through peer support and access to information and resources. He received his MBA from Harvard Business School and earned his bachelor’s degree in Economics from Brandeis University.

Mark Smith, M.D., Board Member

Mark is a Professor of Clinical Medicine at the University of California at San Francisco and Visiting Professor at the School of Public Health at the University of California at Berkeley. He co-chairs the Guiding Committee of the Health Care Payment Learning and Action Network. A nationally recognized leader in healthcare improvement and health policy, Mark was the founding president and former CEO of the California HealthCare Foundation, a philanthropic organization focused on improving the health of Californians, which he led from 1996 to 2013. He was elected to the Institute of Medicine in 2001.

Gillian Munson, Board Member

Gillian is a partner at Union Square Ventures, a venture capital firm based in New York City, and has more than 25 years of corporate experience in the financial and technology industries. Prior to her current role, she spent seven years as Chief Financial Officer for XO Group, Inc., an online media and technology company, which she and her team sold in 2018. Previously, Gillian served as Managing Director at Allen & Company and Executive Director of Equity Research at Morgan Stanley. She also serves on the boards of Sweet Briar College and the St. Regis Foundation.

Cheryl Pegus, M.D., Board Member

Cheryl is the Chief Medical Officer and Senior Vice President, Health Care Services, of Cambia Health Solutions. Prior to joining Cambia, she was the President of Caluent, a healthcare data analytics company, and Clinical Professor of Medicine and Population Health at NYU Langone Medical Center. She also served as Walgreen Co.’s first Chief Medical Officer and as Aetna’s Head of Clinical Products.

Cheryl is a recognized leader in addressing gaps in care and cost among underserved populations. She is the Board Chair for the Association of Black Cardiologists and a board member with Tactile Medical and US Acute Care Solutions, as well as a previous board member with the Care Continuum Alliance.